Remission is a realistic goal for schizophrenia

Irish psychiatrists have been urged to re-examine some of their assumptions about prescribing long-acting injectable antipsychotics for patients with schizophrenia. When considering treatment goals for such patients there are a number of beliefs that colour many psychiatrists’ thinking, according to Prof Sam Keith, Milton Rosenbaum Professor of Psychiatry and Psychology and Chairman of the Department of Psychiatry at the University of New Mexico. He was speaking to Irish psychiatrists at a series of meetings entitled ‘Raising the Bar: Can we Change Our Treatment Goals in Schizophrenia with a Long-Acting Formulation?’ {openx:269} The first assumption to re-examine, he said, was that…